Kubota Pharmaceutical Holdings News

Kubota Pharmaceutical Holdings: Notice of obtaining a new patent related to Kubota glasses technology in the United States

Nov 21 10:00

Kubota Pharmaceutical Holdings: Notice of relocation and integration of “Kubota Glass” directly managed stores

Nov 20 14:30

Kubota Pharmaceutical Holdings: Consolidated Financial Results for the Nine Months Ended September 30, 2024 (under IFRS)

Nov 14 14:30

Kubota Pharmaceutical Holdings: Notice regarding the monthly exercise status of the 33rd Stock Acquisition Rights (with exercise price amendment clause)

Nov 1 07:30

Kubota Pharmaceutical Holdings: Notice of progress of specific clinical research using the at-home/remote ophthalmology retinal monitoring device “eyeMO”

Oct 24 14:00

Kubota Pharmaceutical Holdings: Notice of obtaining a new patent in the US

Oct 3 10:00

Kubota Pharmaceutical Holdings: Notice regarding the monthly exercise status of the 33rd Stock Acquisition Rights (with exercise price amendment clause)

Oct 1 07:30

Kubota Pharmaceutical Holdings: Notice of obtaining a new patent in the US

Sep 12 10:00

Kubota Pharmaceutical Holdings: Notice regarding the monthly exercise status of the 28th Stock Acquisition Rights (with exercise price amendment clause)

Sep 2 07:30

Kubota Pharmaceutical Holdings: Consolidated financial results for the six-month period ending June 30, 2024 (based on IFRS).

Aug 14 14:00

Kubota Pharmaceutical Holdings: Announcements of individual stocks regarding business partnership with Sojitz Kyushu Corporation.

Aug 8 07:50

Kubota Pharmaceutical Holdings: Announcements of individual stocks on the monthly exercise status of the 28th subscription rights (with exercise price adjustment clause).

Aug 1 07:30

Kubota Pharmaceutical Holdings: Announcements of individual stocks for new patent acquisition in the USA.

Jul 25 10:00

Kubota Pharmaceutical Holdings: Announcements of individual stocks: Notice of delivery of 'Kubota Glass' to Sanyo Kyushu, the partnership has started to expand sales in China.

Jul 22 10:00

Kubota Pharmaceutical Holdings: Decision to rationalize management by transferring research, development, and management bases from USA to Japan.

Jul 17 14:00

Kubota Pharmaceutical Holdings: Announcements of individual stocks on the monthly exercise status of the 28th subscription rights (with exercise price adjustment clause).

Jul 1 07:30

Kubota Pharmaceutical Holdings: (Correction) Partial correction of 'Japan Retinal Pigmentary Dystrophy Association submits request to PMDA for early approval of 'Emiclustat hydrochloride' a candidate for Stargardt disease treatment'.

Jun 6 13:00

Kubota Pharmaceutical Holdings: The Japan Macular Degeneration Association submitted a request letter to PMDA, seeking early approval for the candidate drug for Stargardt's disease treatment, Emixustat hydrochloride.

Jun 6 10:00

Kubota Pharmaceutical Holdings: Notice regarding the monthly exercise status of the 28th Stock Acquisition Rights (with exercise price amendment clause)

Jun 3 07:30

KUBOTA PHARMACEUTICAL HLDGS: Notice of obtaining a new patent in the US

May 23 10:00